
Yatharth Hospitals Reports Strong Financial Performance with 47% Year-over-Year Revenue Growth
Noida, May 25, 2026: Yatharth Hospital and Trauma Care Services Ltd, a major private super-speciality hospital chain operating across North India, today announced its financial results for the quarter ending March 31, 2026. The company reported significant growth, driven by its expanding network and the strong performance of newer facilities.The financial results for the fourth quarter of fiscal year 2026 show robust growth metrics, with the company's revenue reaching a record high.
Financial Performance Snapshot
The following table provides a detailed look at the key financial metrics for the latest quarters:| Particulars (Rs Mn) | Q4 FY26 | Q4 FY25 | YoY (%) | Q3 FY26 | QoQ (%) | FY26 | FY25 | YoY (%) |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3,416 | 2,330 | 47% | 3,214 | 6% | 12,072 | 8,856 | 36% |
| EBITDA | 799 | 583 | 37% | 751 | 6% | 2,921 | 2,254 | 30% |
| EBITDA Margin | 23.4% | 25.0% | (161)bps | 23.4% | 1 bps | 24.2% | 25.4% | (125)bps |
| Profit After Tax | 447 | 387 | 15% | 431 | 4% | 1,703 | 1,306 | 30% |
Operational Growth Drivers
The company highlighted that the overall operating revenue reached Rs 3,416 mn during the quarter, representing a 47% year-over-year increase.Growth momentum was particularly strong across newer hospital locations, including Greater Faridabad, Faridabad Sector-20, New Delhi, and Agra. These newer facilities contributed Rs 753 mn in revenues, accounting for 22% of the Group's total revenues. Existing hospitals maintained strong momentum, reporting 29% year-over-year growth.
Group ARPOB (All Revenue Per Occupied Bed) increased to Rs 33,283, a 5% year-over-year rise, reflecting an increasing share from high-value specialities. Specific regional strongholds included:
- Noida Extension reported a strong ARPOB of Rs 47.8k, up 23% YoY.
- Greater Noida reported an ARPOB of Rs 40.3k, up 15% YoY.
New hospitals are also demonstrating encouraging ARPOBs, with the New Delhi facility reporting approximately Rs 40k and Faridabad Sector-20 reporting around Rs 38k, both derived 100% from cash and TPA patients. Furthermore, the recently acquired Gurugram facility holds an ARPOB potential exceeding Rs 50k.
In terms of profitability, EBITDA stood at a record Rs 799 mn, marking a 37% year-over-year increase. Profit After Tax (PAT) was Rs 447 mn, representing a 15% year-over-year growth.
Balance Sheet Strength and Future Expansion
The Group continued to showcase a strong financial position. Operating Cash Flows stood at Rs 2,866 mn for FY26, maintaining a 98% Cash Conversion Ratio. The company successfully reduced its debtor days to 112 days, compared to 125 days in the previous year.Management noted that the recently acquired Gurugram facility is expected to commence operations at the beginning of the next fiscal year, which will strengthen the Group's presence in the highly competitive National Capital Region (NCR) market.
Commenting on the results, Mr. Yatharth Tyagi, Whole Time Director, Yatharth Hospitals, stated, "The quarter and indeed the full year reflects our capabilities in not only acquiring newer hospitals, but also in integrating, scaling, and turning these assets into profitability. The rapid scale-up of our newer hospitals at Model Town (New Delhi), Faridabad Sector-20, and Agra, and our entry into Gurugram with a 250-bed ultra-modern, high-end hospital, enhance our positioning within the NCR market."
YATHARTH Stock Price Movement
As of 2:30 PM, shares of Yatharth Hospital & Trauma Care Services Limited are slipping by 4.49% in live trading, currently at ₹823.4. The equity shed ₹38.75 today, notably recalling that it previously hit its 52-week high of ₹889.9, with 1.50 million shares traded.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.